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Many bacterial pathogens employ a type III secretion system to deliver type III secreted effectors (T3SEs) into host cells,
where they interact directly with host substrates to modulate defense pathways and promote disease. This interaction
creates intense selective pressures on these secreted effectors, necessitating rapid evolution to overcome host
surveillance systems and defenses. Using computational and evolutionary approaches, we have identified numerous
mosaic and truncated T3SEs among animal and plant pathogens. We propose that these secreted virulence genes have
evolved through a shuffling process we have called ‘‘terminal reassortment.’’ In terminal reassortment, existing T3SE
termini are mobilized within the genome, creating random genetic fusions that result in chimeric genes. Up to 32% of
T3SE families in species with relatively large and well-characterized T3SE repertoires show evidence of terminal
reassortment, as compared to only 7% of non-T3SE families. Terminal reassortment may permit the near instantaneous
evolution of new T3SEs and appears responsible for major modifications to effector activity and function. Because this
process plays a more significant role in the evolution of T3SEs than non-effectors, it provides insight into the
evolutionary origins of T3SEs and may also help explain the rapid emergence of new infectious agents.
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Introduction
The type III secretion system (T3SS) and the proteins that
traverse it are essential components of the virulence arsenal
of many destructive bacterial pathogens. Pathogens utilize
the T3SS to inject type III secreted effectors (T3SEs) into the
host cell cytosol where they function to promote disease by
facilitating cell attachment and entry, suppressing the host
defense response, and modulating vesicular trafﬁc, the host
cytoskeleton, and hormones [1–3]. Consequently, T3SEs play
a prominent role in bacterial pathogenesis and host-
association [4] .
T3SEs are modular proteins, with the signals required to
direct secretion from the bacterial cell and translocation into
the host cell generally localized to the N terminus of the
protein, and the functional domains typically localized to the
central and C-terminal portions [5,6]. This modularity has
been exploited in genetic screens designed to identify new
T3SEs [7–9] and for creating reporters to monitor T3SS-
dependent secretion [6,10]. Another feature common to the
vast majority of T3SEs is that they are co-regulated with the
assembly of the T3SS. This is achieved through T3SS-speciﬁc
transcription factors that bind regulatory motifs found
immediately upstream of nearly every T3SE and T3SS
structural gene [11]. Motifs include the Pseudomonas hrp box
[12], the Salmonella ssrAB box [13], and the Xanthomonas pip
box [14]. An important functional consequence of the
respective locations of these two T3SE features is that the
regulatory motifs required for transcriptional activation of
T3SEs are tightly linked to the signals required for secretion
and translocation.
Despite several commonalities, T3SEs are evolutionarily
diverse and highly variable in their distribution, both within
and among species [9]. Their intimate interactions with host
factors expose them to very strong selective pressures [15,16]
resulting in their rapid evolutionary turnover [17,18]. Given
their high degree of genetic diversity, it is perhaps not
surprising that a number of studies have identiﬁed T3SEs that
are truncated or chimeras of other sequences [10,19–22];
nevertheless, no study has recognized this particular form of
variation as being signiﬁcant from the perspective of either
evolution or function. Here, we report on an evolutionary
process that plays an extremely important role in the
evolution of new T3SEs. Unlike previous studies that have
reported the introduction of genetic variation through
homologous intragenic recombination [23–28], the evolution
of T3SEs is strongly inﬂuenced by a non-homologous
recombinational process that is analogous to exon shufﬂing
seen in eukaryotes. This process not only explains the high
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insight into how the particular structure of these genes
contributes to dramatic evolutionary and functional changes
that may play a key role in the ongoing arms race between
pathogen and host.
Results/Discussion
The complete nucleotide and protein sequences of all
experimentally conﬁrmed T3SEs were collected from the 23
species having at least one characterized T3SE (Table S1).
Using a combination of BLASTP, TBLASTX, and pair-wise
BLAST (BL2SEQ), we identiﬁed two common and interre-
lated features among T3SEs from all species. First, the N or C
terminus of many T3SEs are homologous (E value ,10
 5)t o
other loci or open reading frames. We will refer to these
homologs as orphan effector termini (ORPHETs). Second,
many T3SEs are chimeras of either two known T3SEs, or a
T3SE and another gene.
ORPHETs and chimeric T3SEs were found in nine species,
representing plant pathogens, animal pathogens, and mutu-
alists. The largest number of chimeric T3SEs and ORPHETs
were identiﬁed in the species with the largest T3SE
repertoires, which included Pseudomonas syringae (12 of 56
T3SE families, 21%), Salmonella enterica (5/28, 18%), and
Xanthomonas campestris (7/22, 32%) (Table 1). The high
frequency of ORPHETs and chimeric effectors has led us
to propose that the evolution of new T3SEs frequently
occurs by the reassortment of termini from preexisting
T3SEs. This stochastic process, which we will refer to as
‘‘terminal reassortment,’’ involves the fusion of an existing
T3SE N terminus to another T3SE, or an unrelated coding
or non-coding sequence (Figure 1). Alternatively, terminal
reassortment may occur via a large deletion that brings the
N terminus of a T3SE into contact with a region down-
stream of the effector (Figure 1). Terminal reassortment
does not describe or rely on a speciﬁc recombinational
mechanism, but rather describes an evolutionary process
that results in the rapid formation of new T3SEs via a single
quantum evolutionary step in which the regulatory and
secretion/translocation signals are coupled to new sequen-
ces.
P. syringae, which has approximately 190 T3SE homologs and
derivatives distributed among 56 T3SE families [10], provides
the most interesting examples of ORPHETs and ORPHET-
derived T3SEs. For example, one group of related T3SEs in P.
syringae contains two ORPHETs, HopW1–2PmaES4326 and
HopW1–2Pph1448A, and two larger T3SEs, HopW1–1PmaES4326
and HopAE1PsyB728a, all of which are homologous along their
ﬁrst 85 amino acids (Figure 2A). The two ORPHETs are clearly
related to the N terminus of the larger T3SEs, while the two
larger T3SEs are chimeras themselves, with HopW1–
1PmaES4326 sharing C-terminal homology to a prophage-
related sequence from Escherichia coli O157:H7 EDL933, and
HopAE1PsyB728a [29] sharing C-terminal homology to several
putative Xanthomonas virulence genes. These data suggest that
all four of these loci derived from a common N-terminal
ORPHET. Indeed, hopW1–1PmaES4326 is situated near its
ORPHET on plasmid pPMA4326B and is ﬂanked by numerous
IS elements [30]. All of these related T3SEs except hopW1–
1PmaES4326 also have a highly conserved ribosome-binding site
and hrp box. Surprisingly, the upstream region of hopW1–
1PmaES4326 is closely related to the upstream region of a
completely unrelated P. syringae pv. tomato DC3000 T3SE,
hopD1 (64% nucleotide identity over 300 bp) (Figure 2A). This
exchange of promoters is functionally signiﬁcant since
changes to the hrp box sequence and its relative distance
from the start codon has been shown to alter T3SE expression
and bacterial virulence [31].
An analysis of the ﬂanking regions of ORPHETs indicates
that they are not merely misannotations due to frameshift
mutations in ‘‘full-length’’ T3SEs, nor are they incomplete
sequence submissions. ORPHETs are homologous to their
respective T3SEs and exhibit both conservation in either
their 59 or 39 ﬂanking regions (Table S2), and variation at the
end of their protein-coding region, which is consistent with
random mobilization and insertion, or large-scale deletion
downstream of the T3SE secretion signal. Furthermore,
because a single ORPHET can constitute the N terminus of
multiple effectors, as with the HopW1/HopAE1 (Figure 2A)
and HopAB3 effector families (Table 1), ORPHETs likely
serve as precursors for the formation of new T3SEs.
Xanthomonas provides an excellent example of chimeric
T3SEs. T3SEs XopJ [32], AvrXccE1, and hypothetical protein
XAC3230 [33] share a common N terminus, but show
absolutely no similarity throughout their C terminus (Figure
2B). The 100-bp region immediately upstream of all three
effectors shares 70% nucleotide identity and contains a
highly conserved ribosome-binding site and pip promoter
box.
Seven S. enterica effectors, srfH/sseI, sseJ, sspH1, sspH2, slrP,
sifA, and sifB share a common N terminus [21,34,35] and
provide some of the most complex and interesting examples
of terminal reassortment. This group comprises four distinct
homology groups, with group I containing the full-length
homologs SspH1, SspH2, and SlrP; group II containing SseJ;
group III containing the relatively divergent full-length
homologs SifA and SifB; and group IV containing only
SrfH/SseI (Figure 3A). There is no sequence similarity among
the C termini of those T3SEs from the different groups. One
example of terminal reassortment within this group involves
SspH2 and SrfH, which share 88% amino acid identity in
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Synopsis
Many pathogenic bacteria rely on specialized virulence proteins to
cause disease. These proteins, known as type III secreted effectors
(T3SEs), are directly injected into the host’s cells and facilitate the
disease process by interacting with host proteins and interfering
with the defense response. Although most T3SEs lack any sequence
similarity, several T3SEs share a common terminus, suggesting that
part of these proteins was derived from the same sequence. The
authors propose an evolutionary mechanism, called ‘‘terminal
reassortment,’’ in which the termini of T3SEs reassort with other
genetic information to create new chimeric proteins. This study
shows that this process has given rise to T3SEs with new virulence
functions and that it may influence bacterial host specificity.
Chimeric T3SEs are present in eight different genera and in some
cases are present in as many as 32% of known T3SE families. This is
significantly more than what is found in other protein families,
suggesting that terminal reassortment plays a disproportionately
important role in the evolution of T3SE. Terminal reassortment may
lead to the very rapid evolution of new T3SEs, thereby contributing
to the emergence of new infectious diseases.their N terminus and 98% identity in the 257 bp immediately
upstream of their coding region that includes the ssrAB
promoter box (Figure 3B). A second, yet more complex
example, was identiﬁed within the full-length group I
homologs, using the phylogenetic-based method of boot-
scanning on a nucleotide alignment of sspH1, sspH2, slrP, and
the group IV effector sseI/srfH. Bootscanning is a general
method for identifying recombination breakpoints based on
incongruence among genealogies constructed from sub-
regions within a locus. The bootscan revealed that SspH1 is
a recombinant protein composed of an SlrP N terminus and
an SspH2 C terminus, with a clear breakpoint near base 400
(Figure 3C). Interestingly, SlrP and SspH1, which share the
most similar N terminus, are translocated by both S. enterica
T3SS secretion systems SPI-1 and SPI-2, while all others are
translocated by only SPI-2 [36]. This suggests the presence of
a common chaperone binding domain or motif within the N
terminus of these two functionally distinct proteins, in
addition to the already identiﬁed WEK(I/M)XXFF motif [35],
which permits translocation by both SPI-1 and SPI-2.
Terminal reassortment has been demonstrated experimen-
tally in genetic screens designed to identify T3SS-speciﬁc
substrates [7–9]. In these screens, an effector C terminus
(reporter) is linked to a transposon, which integrates
randomly in the bacterial genome, occasionally creating a
functional fusion with an appropriate T3SS regulatory and
secretion signal. Using these and related techniques, secre-
tion and translocation into the host has been experimentally
demonstrated for many ORPHETs, including HopAT1 [42]
and HopS1 [43] from P. syringae, and OspD1 [44] and OspG
Figure 2. Genetic Organization of ORPHETs and Chimeras Illustrating Conserved Regulatory and Protein-Coding Regions
Homologous gene regions within each panel share the same coloring. The coding region of each T3SE starts at the beginning of the solid black bar,
although the length of the upstream region is not to scale with the coding region. The promoter sequences and ribosome-binding sites are indicated,
but not shown to scale. Variable residues in these sequences have been highlighted in gray.
(A) The three HopW1 family members along with HopAE1PsyB278a in P. syringae share N-terminal homology that extends to the upstream region and
includes the ribosome-binding site and hrp box promoter. The hrp box promoter of HopW1–1PmaES4326 and flanking region, however, is more closely
related to that of HopD1PtoDC3000, although these two proteins are not homologous.
(B) Xanthomonas spp. effectors XopJ and AvrXccE1 along with hypothetical protein XAC3230 share a common N terminus and display conservation
upstream of the protein-coding region.
DOI: 10.1371/journal.ppat.0020104.g002
Figure 1. Proposed Mechanisms of Terminal Reassortment
ORPHETs containing the appropriate regulatory and secretion signals may evolve independently or be derived from another effector. ORPHETs can be
mobilized and integrated randomly into the genome, capturing either an existing gene or a non-coding region and thereby instantaneously creating a
new chimeric effector. Alternatively, deletions downstream of an N-terminal secretion signal may also result in the formation of a new fusion protein.
DOI: 10.1371/journal.ppat.0020104.g001
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Type III Effector Evolution[45] from Shigella ﬂexneri. As with these contrived screens, the
natural evolutionary process of terminal reassortment likely
involves mobile genetic elements such as insertion sequences,
integrative conjugative elements, phage, and plasmids. In-
deed, over 50% of ORPHETs or chimeric T3SEs are
associated with mobile elements (Table 1). Many effectors
are plasmid-borne, placing them on a genome that is typically
in genetic ﬂux and susceptible to frequent rearrangements.
Prophage are also implicated in terminal reassortment,
illustrated by C-terminal homology of effectors EspFu and
HopW1–1ES4326 to prophage-related genes. Phage may serve
as mixing vessels for T3SEs, or provide the novel genetic
variation and homologous sequence for recombination. Both
phage and plasmids, as well as transposable elements,
ultimately provide multiple copies of ORPHETs or T3SE
precursors. Consequently, terminal reassortment can occur
without loss of the original effector or ORPHET.
An analysis of the relationship between the number of
ORPHETs and chimeras, and the number of T3SE homology
families identiﬁed for each species (Figure 4A) reveals a very
strong linear relationship (R
2 ¼ 0.91, p , 0.0001, Figure 4B),
reinforcing the signiﬁcance of terminal reassortment on the
evolution of T3SEs. Approximately one out of every 4.2 T3SE
families (weighted mean ¼ 24% of T3SE families) carries an
ORPHET or chimeric T3SE. This is signiﬁcant because it
indicates that terminal reassortment is strongly inﬂuencing
the evolution of T3SEs. Additional support for the impor-
tance of terminal reassortment in the evolution of T3SE is
apparent when the frequency of ORPHETs and chimeras in
T3SE homology families is compared to the frequency of
truncated and chimeric loci among families of non-T3SE
proteins. To reduce bias introduced by incomplete T3SE
inventories, we conducted this analysis on P. syringae, X.
campestris, and S. enterica, which have the largest, best-
characterized effector complements. While, on average,
24% of T3SE families have at least one ORPHET or chimera,
only 7% of non-T3SE protein families were found to carry a
truncated or chimeric locus among the 2,943 protein families
of P. syringae (204 gene families, p ¼ 3 3 10
 5, two-tailed chi-
squared test), the 2,760 non-T3SE protein families of S.
enterica (198 gene families, p ¼ 0.03), and the 2,688 non-T3SE
protein families of X. campestris (195 genes, p ¼ 1 3 10
 5).
Transporters (18%) and regulators (10%) are among the most
highly represented functional groups among the 204 non-
T3SE truncated or chimeric loci in P. syringae. Interestingly,
proteins that are expected to be under strong selective
pressures (e.g., outer membrane proteins, alginate biosyn-
thetic genes, type IV pilus subunits) only represent 4% of
these chimeras.
T3SEs are assumed to be predominantly associated with the
ﬂexible genome—the part of the genetic compliment that
varies among strains within a species. Given this, it is possible
that terminal reassortment simply occurs more frequently in
the ﬂexible genome, and therefore, our observations are a
consequence of the genomic context of T3SEs, rather than
something inherent to T3SEs themselves. To address this, we
determined that 28.3% of all P. syringae coding sequences are
absent from one or two of the three sequenced P. syringae
genomes (Nahal and Guttman, unpublished data) and are
therefore putatively components of the ﬂexible genome. In
comparison, only 9.3% of the 204 non-T3SE truncated and
chimeric loci were absent from one or two of the three
sequenced P. syringae strains. One would expect a larger
fraction of the non-T3SE truncated and chimeric loci to be in
the ﬂexible genome if terminal reassortment were simply a
byproduct of those processes acting on the ﬂexible genome.
Figure 3. Terminal Reassortment among Effectors in Salmonella enterica
(A) N-terminal homology among seven effectors of S. enterica represent-
ing four distinct homology groups. Each homology group has been
encapsulated in a shade of blue and contains proteins that share full-
length homology. The interconnecting lines indicate the degree of N-
terminal relatedness, with dashed lines indicating ,40% similarity, thin,
solid lines 40%–60% similarity, and thick, solid lines .60% similarity.
(B) S. enterica effectors sspH2 and srfH share a highly conserved upstream
region, ssrAB promoter box, and N-terminal region, while the C terminus
of these proteins is non-homologous.
(C) Bootscan of the homologous S. enterica effectors sspH1, sspH2, slrP,
and N-terminal homolog sseI/srfH to detect recombination, with the
nucleotide sequence of sspH1 as the query sequence. sseI/srfH had ,35%
permuted trees and was omitted from the figure. Bootscanning was
performed with Simplot v 3.5.1 using neighbor joining with the F84
model, gapstrip off, and window and step sizes of 200 and 20,
respectively. Other members of this effector family were excluded to
facilitate optimal nucleotide alignment.
DOI: 10.1371/journal.ppat.0020104.g003
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Type III Effector EvolutionFurthermore, 69.7% of the 204 non-T3SE truncated or
chimeric loci have homologs in Pseudomonas putida, Pseudomo-
nas aeruginosa, and Pseudomonas ﬂuorescens, further supporting
the contention that these loci are not components of the
ﬂexible genome. Clearly, the processes that are responsible
for the evolutionary dynamics of the ﬂexible genome are not
strictly responsible for the formation of chimeras and
ORPHETs.
We believe that the high frequency of ORPHETs and
chimeras among T3SE is due to three key features that are
collectively unique to T3SEs. First and foremost, T3SEs are
modular [5,6], with all of the signals required for expression,
secretion, and translocation located in close proximity.
Second, T3SEs are under intense selective pressures due to
their central roles in pathogenesis and host adaptation [16].
Third, T3SEs are commonly associated with mobile elements
[40,41], which can act as catalysts for the reassortment of
linked loci.
Horizontal gene transfer also likely plays an important role
at all levels of the terminal reassortment process. Horizontal
gene transfer may be responsible for the supply of precursor
ORPHETs and T3SEs and the introduction of novel genetic
variation that will eventually serve as the target. Horizontal
gene transfer may even lead to the intra- or inter-speciﬁc
dissemination of the new chimera following terminal reas-
sortment. The association of ORPHETs and T3SEs with
multi-copy mobile elements provides a substantial pool of
these elements, and as a result, terminal reassortment does
not necessarily lead to loss of the original T3SE or ORPHET
precursor.
Terminal reassortment may fundamentally affect bacterial
virulence and host speciﬁcity. For example, the P. syringae
T3SEs HopD1 and HopAO1 are N-terminal chimeras that
have different biological functions due to their unique C
termini. Unlike HopD1, the C terminus of HopAO1 has
tyrosine phosphatase activity, which is responsible for the
suppression of the innate immune response of Nicotiana
benthamiana [22,37]. Since only one of these two related
T3SEs has tyrosine phosphatase activity, terminal reassort-
ment has in this case given rise to T3SEs that may act in a
host-speciﬁc manner. A similar situation is found with the
Xanthomonas chimeras XopJ and AvrXccE1. XopJ and other
members of the YopJ family have SUMO isopeptidase
activity governed by a catalytic triad of histidine, glutamic
acid, and cysteine residues [3,38]. This catalytic triad is
present in XopJ, but absent from its N-terminal homolog
AvrXccE1, making it very likely that these two effectors have
different biological functions. Another example comes from
the chimeric T3SEs SspH2, SspH1, and SlrP, which have
been shown to differentially modulate Salmonella host
speciﬁcity. SspH1 and SspH2 contribute to Salmonella
virulence in calves, while SlrP plays a similar role during
infection of mice [35,39]. Since these chimeric T3SEs have
differential effects in different hosts, they can be considered
host-speciﬁcity factors.
Because ORPHETs are often mobilized with their upstream
regulatory and binding motifs, virtually any coding or non-
coding gene segment can be instantly recruited by an N-
terminal secretion domain to serve as part of a new T3SE with
potentially new virulence function, effectively making a novel
virulence protein in a single quantum step. The random
shufﬂing of any one ORPHET or T3SE has only a small
probability of giving rise to a functional protein that is of use
to the bacterium. Nevertheless, over evolutionary time,
terminal reassortment will produce a wide spectrum of novel
proteins, some of which will confer a selective advantage to
their bacterial host. These proteins may persist and even
become ﬁxed in the population. This evolutionary process, a
bacterial version of Goldschmidt’s hopeful monster, has
signiﬁcant implications for pathogenicity and virulence as it
enables the near instantaneous evolution of novel genes or
altered expression patterns that can permit the bacterium to
evade host defenses or exploit new eukaryotic targets. It will
be interesting to determine if this remarkably simple and
efﬁcient evolutionary process is responsible for some of the
dramatic host-speciﬁcity shifts that underlie the emergence
of new infectious agents.
Figure 4. Frequency of ORPHETs and Chimeras among Bacterial
Pathogens
(A) Histogram illustrating the number of effector families analyzed for
each species and the number of ORPHETs/chimeras identified for each.
(B) Regression analysis of the number of effector families versus the
number of ORPHETs/chimeras identified for each given species, r
2¼0.91.
DOI: 10.1371/journal.ppat.0020104.g004
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Bioinformatic identiﬁcation of chimeric effectors. Nucleotide and
protein sequences of all known and experimentally conﬁrmed T3SEs
were collected from NCBI following extensive literature and database
searches. Genera analyzed include Aeromonas, Bartonella, Bordetella,
Bradyrhizobium, Brucella, Burkholderia, Citrobacter, Chromobacterium, Chla-
mydia, Escherichia, Edwardsiella, Haemophilus, Mesorhizobium, Pantoea,
Photorhabdus, Pseudomonas, Ralstonia, Rhizobium, Salmonella, Shewanella,
Shigella, Sinorhizobium, Sodalis, Vibrio, Xanthomonas, and Yersinia. The
NCBI nr database was searched with BLASTN, BLASTP, and
TBLASTX to identify candidate chimeras and ORPHETs, with
subsequent veriﬁcation achieved with BL2SEQ and DIALIGN2. A
protein was considered an ORPHET if its full-length sequence had
.45% similarity to the N or C terminus of a different protein.
Similarly, two proteins were considered chimeras if they shared
.45% similarity in either terminus. In both cases, similarity was
required to begin within 30 amino acids of their start position for N-
terminal homologs and 30 amino acids of their stop position for C-
terminal homologs. Sequences ﬂanking effectors were extracted from
NCBI manually and compared using BL2SEQ and ClustalX1.83 [46].
Upstream promoter sequences and ribosome-binding sites were
identiﬁed and extracted manually from available sequence data,
except for hopAB3–2PmaES4326, whose upstream sequence was obtained
by inverse PCR (see below). Hrp box promoter sequences for
Pseudomonas syringae will be deposited at the PPI site: http://www.
pseudomonas-syringae.org.
Phylogenetic analyses and bootscanning. Phylogenetic trees were
constructed using alignments generated with ClustalX1.83 using
MEGA3 [47]. The JTT amino acid substitution model was used with
pair-wise deletion and 1,000 bootstrap replicates. Bootscanning was
performed with Simplot v 3.5.1 [48] using neighbor joining with the
F84 (maximum likelihood) model, gapstrip off, and window and step
sizes of 200 and 20, respectively. The inclusion of the group IV
Salmonella effectors was required for this analysis as bootscanning
requires a minimum of four sequences. Because the other effector
groups were highly divergent, they were excluded from the analysis to
facilitate optimal nucleotide alignment. A signiﬁcant recombination
event is usually indicated by a percentage of permuted trees over
70%.
Proteomic comparison and analyses. The genome-wide identiﬁca-
tion of non-T3SE truncated and chimeric loci was performed with
PERL scripts using the complete proteomes of P. syringae pv. tomato
DC3000 (5,470 proteins) [49], Xanthomonas campestris pv. vesicatoria
85–10 (4,487 proteins) [50], and Salmonella enterica subsp. enterica
serovar Typhi str. CT18 (4,395 proteins) [51]. Following the
exclusion of transposable elements, type III effectors, pseudogenes,
and leader peptides, each proteome was categorized into homology
groups (2,943 for P. syringae, 2,688 for X. campestris, and 2,760 for S.
enterica) based on COG designation. Proteins not belonging to an
established COG were BLASTed against the entire proteome and
grouped together if they shared 70% similarity over 70% of their
length. All homology groups were examined for evidence of
chimeras and ORPHET-like derivation by BLASTP against a custom
database, yielding 204 chimeras/ORPHETs for P. syringae, 195 for X.
campestris, and 198 for S. enterica. The custom P. syringae database
included P. syringae pv. tomato DC3000, P. syringae pv. phaseolicola
1448A, and P. syringae pv syringae B728a, as well as proteins from
fully sequenced plasmid genomes (pDC3000A, pDC3000B, p1448A-
A, p1448A-B, pFKN, pPSR1, pPMA4326A, pPMA4326B). For S.
enterica, the custom database included S. enterica ATCC9150, S.
enterica SC-B67, S. enterica CT18, and S. enterica TY2, as well as fully
sequenced plasmid genomes (pBERT, pCryptic, pHCM1, pHCM2,
pKDSC50, pOU1113, pSC138, pSCV50). The custom Xanthomonas
database included the proteomes of X. campestris pv. vesicatoria 85–
10, X. campestris pv. campestris 8004, X. campestris pv. campestris
ATCC33913, and the four plasmids, pXCV2, pXCV19, pXCV38, and
pXCV183. A two-tailed chi-squared test was used to compare the
relative impact of terminal reassortment on P. syringae effector
families (n ¼ 56), S. enterica effector families (n ¼ 28), and X. campestris
effector families (n ¼ 28) versus the P. syringae (n ¼ 2,943), the S.
enterica (n ¼ 2,760), or the X. campestris (n ¼ 2,688) non-effector
datasets, respectively. The classiﬁcation of the 204 P. syringae non-
T3SE truncated and chimeric loci into ‘‘core’’ and ‘‘ﬂexible’’ was
achieved by BLAST analysis of a single chimeric representative from
each family against a custom database comprising the proteomes of
the three sequenced P. syringae strains (P. syringae pv. tomato
DC3000, P. syringae pv. syringae B728A, and P. syringae pv.
phaseolicola 1448A), Pseudomonas putida KT2440, Pseudomonas ﬂuo-
rescens Pf-5, and Pseudomonas aeruginosa PAO1. Proteins were
considered orthologous if they shared .45% amino acid similarity
over their entire lengths and had a BLAST expect value less than
10
 20. Regression analyses were performed with StatView version
5.0.1 (SAS Institute) using data from all bacteria having at least one
conﬁrmed T3SE.
Inverse PCR and DNA sequencing. Genomic DNA of P. syringae pv.
maculicola ES4326 was extracted using the Puregene DNA isolation
kit (Gentra Systems, Minneapolis, Minnesota, United States). Ap-
proximately 8 lg of genomic DNA was completely digested with
BsaAI (New England Biolabs Incorporated, Beverly, Massachusetts,
United States) and self-ligated at 16 8C overnight using T4 DNA
ligase. The upstream region of hopAB3–2PmaES4326 was obtained by
inverse PCR with 20 ng of self-ligated DNA as template, using the
primers 59GGCTCTGTTGATACTACCCACCATG 39 and 59
GTGCCGCTACCGCCGTGCC 39 at an annealing temperature of 57
8C. The DNA sequence of the single 420-bp PCR product was
obtained with the same primers using a CEQ8000 sequencer
(Beckman Coulter Incorporated, Fullerton, California, United
States).
Supporting Information
Table S1. T3SE Proteins from 21 Different Genera
Found at DOI: 10.1371/journal.ppat.0020104.st001 (199 KB DOC).
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